Alnylam Pharmaceuticals (ALNY) Retained Earnings (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) posted Retained Earnings of -$6.33 billion for Q2 2026, compared with -$7.41 billion a year earlier.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Retained Earnings (2009 - 2026) Analysis & Trends
At the end of FY2025, Alnylam Pharmaceuticals' Retained Earnings came in at -$6.7 billion.
- In prior years, Alnylam Pharmaceuticals' Retained Earnings was -$7.29 billion in FY2024, -$7.01 billion in FY2023, -$6.57 billion in FY2022 and -$5.44 billion in FY2021.
- The Q2 2026 figure stands as the highest quarterly Retained Earnings since Q2 2022.
- According to Business Quant data, Retained Earnings for the three prior quarters was -$6.5 billion (Q1 2026), -$6.7 billion (Q4 2025) and -$7.16 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 12.59 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | -22.28 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 2.20 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 112.09 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 15.69 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | -6.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.33 Bn |
| Mar 31, 2026 | -6.50 Bn |
| Dec 31, 2025 | -6.70 Bn |
| Sep 30, 2025 | -7.16 Bn |
| Jun 30, 2025 | -7.41 Bn |
| Mar 31, 2025 | -7.35 Bn |
| Dec 31, 2024 | -7.29 Bn |
| Sep 30, 2024 | -7.20 Bn |
| Jun 30, 2024 | -7.09 Bn |
| Mar 31, 2024 | -7.08 Bn |
| Dec 31, 2023 | -7.01 Bn |
| Sep 30, 2023 | -6.87 Bn |
| Jun 30, 2023 | -7.02 Bn |
| Mar 31, 2023 | -6.74 Bn |
| Dec 31, 2022 | -6.57 Bn |
| Sep 30, 2022 | -6.36 Bn |
| Jun 30, 2022 | -5.96 Bn |
| Mar 31, 2022 | -5.68 Bn |
| Dec 31, 2021 | -5.44 Bn |
| Sep 30, 2021 | -5.18 Bn |
API Access
Alnylam Pharmaceuticals Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();